Facts prove the benefits of lowering cholesterol in various populations continues to grow, but questions still remain about screening and treatment of lipid disorders in women, even though data from primary prevention trials in women remain thin, recent trials demonstrating benefits of cholesterol reduction across a broad range of cholesterol levels and cardiac risk in men and women encourage the conclusion that benefits may extend to asymptomatic women who are otherwise at high risk for coronary disease.

Periodic lipid screening beginning in middle age will identify most women who are at high enough risk to merit drug therapy or more detailed consideration of age, diabetes, blood pressure, and other risk factors can more accurately estimate individual risk of coronary heart disease. Advice about healthy diet, weight control, and physical activity can benefit all women.

Advanced Lipoprotein Fingerprinting is a more precise cholesterol test that allows doctors to identify health risks that traditional screens miss. Doctors now have a precise reading not only of a patient's cholesterol levels but other independent risk factors known to be associated with heart disease.

The process separates lipids in the blood to create a detailed cholesterol profile that helps doctors identify patients at risk for heart disease. The detailed graph allows a doctor to precisely analyze a patient's overall risk profile and monitor the effectiveness of a diet or treatment regimen.

This advanced analytical techniques that can help doctors diagnose early warning signs for coronary heart disease, which kills more than 2,600 Americans a day, according to the American Heart Association. High LDL cholesterol is a major cause of coronary heart disease, according to the National Cholesterol Education Program.

Aiming to identify early risk factors, the National Cholesterol Education Program issued guidelines calling for more comprehensive cholesterol screens as well as other risk factors not included in the cholesterol screen.

Early detection, particularly in youth, is the key to slowing down the development of heart disease in later life. Advanced cholesterol screening is a valuable tool that is gaining acceptance among medical insurers.

Texas A&M University researchers created Advanced Lipoprotein Fingerprinting as a more precise cholesterol test that allows doctors to identify health risks that traditional screens miss. LipidLabs further refined the Advanced Lipoprotein Fingerprinting Process and made Advanced Lipoprotein Fingerprinting available for commercialization. LipidLabs' results translate to more accurate and specific data on which to make clinical judgments and guide patient therapy and prevention at reasonable costs.